• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$3.64 -$0.01 (-0.27%)

REAL-TIME: Last trade at

Dynavax Technologies Corp

NASDAQ:DVAX

Jump to this page for:

Related Resources

Avoid These 2 Plunging Biotechs

5/14/2012 by DailyFinance

Company News for May 10, 2012 - Corporate Summary

5/10/2012 by Nasdaq

Dynavax tumbles 24% on stock offer pricing

5/9/2012 by MarketWatch

Why Dynavax Shares Dropped

5/9/2012 by DailyFinance

Johnson & Johnson Raises Forecast; Will Other Drug Companies Follow Suit?

4/18/2012 by DailyFinance

Small and Wildly Successful Hedge Funds Love These 10 Stocks

3/20/2012 by DailyFinance

Insiders Are Not Buying Into the Rally: Cause for Concern?

2/10/2012 by DailyFinance

Dynavax Shares Popped: What You Need to Know

2/2/2012 by DailyFinance

Avoid This Biotech Stock

12/31/2011 by DailyFinance

The 2 Best-Performing Sectors Over the Last Decade

12/20/2011 by DailyFinance

US Commerce Official To Lead Biotech Trade Mission To China, Hong Kong

9/28/2011 by Smart Money

Making Cents in Penny Stocks

9/21/2011 by DailyFinance

10 Health Care Penny Stocks to Buy

5/18/2011 by Nasdaq

17 Stocks Under $5 Being Chased by Big Money Managers

4/28/2011 by Seeking Alpha

7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses

3/29/2011 by Seeking Alpha

20 Short Seller Targets Under $5

1/15/2011 by Seeking Alpha

Data From Dynavax for HBV Candidate: But Is There Enough Visability?

12/27/2010 by Seeking Alpha

Analyst Calls: ALU, AVP, BRCD, CVH, DISH, EL, INTC, NSM, PCS, SWY ...

11/8/2010 by BloggingStocks

Private Biotechs Take Different Avenues to Rake in Cash

9/26/2010 by Seeking Alpha

UPDATE 1-Dynavax's flu vaccine shows promise, shares rise

4/26/2010 by Reuters

UPDATE 1-Dynavax hep B vaccine shows promise in kidney disease

4/14/2010 by Reuters

UPDATE 1-Dynavax to raise $44 mln from public offering

4/13/2010 by Reuters

UPDATE 1-Dynavax hepatitis B vaccine as safe as Glaxo's vaccine

3/23/2010 by Reuters

Dynavax May Seek FDA Approval For Heplisav Earlier Than Expected

3/16/2010 by Smart Money

UPDATE 1-Dynavax gets going-concern warning

3/16/2010 by Reuters

UPDATE:Dynavax May Seek FDA OK For Heplisav Earlier Than Seen

3/16/2010 by Smart Money

UPATE 1-Dynavax says Merck agrees on final reimbursements

3/15/2010 by Reuters

UPDATE 1-Dynavax hepatitis C drug shows promise in phase 1 trial

1/26/2010 by Reuters

UPDATE 2-FDA gives Dynavax OK to resume hepatitis B trials

9/10/2009 by Reuters